Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes

Background/Aims: we have investigated whether cultured cardiomyocytes of the cell line HL-1 have the ability to perform regulatory volume responses both in hypotonic and hypertonic conditions. Furthermore, we characterized those regulatory responses and studied the effects of bumetanide and DIDS in...

Descripción completa

Detalles Bibliográficos
Publicado: 2014
Materias:
RVD
RVI
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10158987_v33_n6_p1745_Cacace
http://hdl.handle.net/20.500.12110/paper_10158987_v33_n6_p1745_Cacace
Aporte de:
id paper:paper_10158987_v33_n6_p1745_Cacace
record_format dspace
spelling paper:paper_10158987_v33_n6_p1745_Cacace2023-06-08T15:59:47Z Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes Bumetanide Cell volume regulation DIDS HL-1 atrial myocytes RVD RVI 4,4' diisothiocyanatostilbene 2,2' disulfonic acid bumetanide hypertonic solution hypotonic solution sodium potassium chloride cotransporter bicarbonate chloride antiporter isotonic solution Ringer solution sodium potassium chloride cotransporter 4,4' diisothiocyanatostilbene 2,2' disulfonic acid bumetanide diuretic agent hypertonic solution hypotonic solution animal cell animal experiment article biological activity cell function cell membrane transport cell swelling cell volume cellular parameters concentration response enzyme inhibition heart muscle cell hyperosmotic stress hypoosmotic stress light intensity light scattering nonhuman osmosis osmotic stress priority journal regulatory mechanism regulatory volume decrease regulatory volume increase Article cell membrane controlled study illumination mouse water flow animal cardiac muscle cell cell line cell size cytology drug effects time factor 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid Animals Bumetanide Cell Line Cell Size Diuretics Hypertonic Solutions Hypotonic Solutions Mice Myocytes, Cardiac Osmosis Time Factors Background/Aims: we have investigated whether cultured cardiomyocytes of the cell line HL-1 have the ability to perform regulatory volume responses both in hypotonic and hypertonic conditions. Furthermore, we characterized those regulatory responses and studied the effects of bumetanide and DIDS in volume regulation of HL-1 cells. Methods: we used a light scattering system to measure the transient volume changes of HL-1 cells when subjected to osmotic challenge. Results: We found that HL-1 cells correct for their volume excess by undergoing regulatory volume decrease (RVD), and also respond to hypertonic stress with a regulatory volume increase (RVI). Rate of RVD was 0.08 ± 0.04 intensity/min, and rate of RVI was 0.09 ± 0.01 intensity/min. Volume recovery was 83.68 ± 5.73 % for RVD and 92.3 ± 2.3 % for RVI. Bumetanide 50 μM inhibited volume recovery, from 92.3 ± 2.3 % (control) to 24.6 ± 8.8 % and reduced the rate of RVI from 0.070 ± 0.020 intensity/min (control) to 0.010 ± 0.005 intensity/min. 50 μM DIDS reduced volume recovery to 42.93 ± 7.7 % and rate of RVI, to 0.03 ± 0.01 intensity/min. Conclusions: these results suggest that bumetanide- and DIDS-sensitive mechanisms are involved in the RVI of HL-1 cells, which points to the involvement of the Na+/K+/2Cl- cotransporter and Cl-/bicarbonate exchanger in RVI, respectively. © 2014 S. Karger AG, Basel. 2014 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10158987_v33_n6_p1745_Cacace http://hdl.handle.net/20.500.12110/paper_10158987_v33_n6_p1745_Cacace
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Bumetanide
Cell volume regulation
DIDS
HL-1 atrial myocytes
RVD
RVI
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
hypertonic solution
hypotonic solution
sodium potassium chloride cotransporter
bicarbonate chloride antiporter
isotonic solution
Ringer solution
sodium potassium chloride cotransporter
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
diuretic agent
hypertonic solution
hypotonic solution
animal cell
animal experiment
article
biological activity
cell function
cell membrane transport
cell swelling
cell volume
cellular parameters
concentration response
enzyme inhibition
heart muscle cell
hyperosmotic stress
hypoosmotic stress
light intensity
light scattering
nonhuman
osmosis
osmotic stress
priority journal
regulatory mechanism
regulatory volume decrease
regulatory volume increase
Article
cell membrane
controlled study
illumination
mouse
water flow
animal
cardiac muscle cell
cell line
cell size
cytology
drug effects
time factor
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
Animals
Bumetanide
Cell Line
Cell Size
Diuretics
Hypertonic Solutions
Hypotonic Solutions
Mice
Myocytes, Cardiac
Osmosis
Time Factors
spellingShingle Bumetanide
Cell volume regulation
DIDS
HL-1 atrial myocytes
RVD
RVI
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
hypertonic solution
hypotonic solution
sodium potassium chloride cotransporter
bicarbonate chloride antiporter
isotonic solution
Ringer solution
sodium potassium chloride cotransporter
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
diuretic agent
hypertonic solution
hypotonic solution
animal cell
animal experiment
article
biological activity
cell function
cell membrane transport
cell swelling
cell volume
cellular parameters
concentration response
enzyme inhibition
heart muscle cell
hyperosmotic stress
hypoosmotic stress
light intensity
light scattering
nonhuman
osmosis
osmotic stress
priority journal
regulatory mechanism
regulatory volume decrease
regulatory volume increase
Article
cell membrane
controlled study
illumination
mouse
water flow
animal
cardiac muscle cell
cell line
cell size
cytology
drug effects
time factor
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
Animals
Bumetanide
Cell Line
Cell Size
Diuretics
Hypertonic Solutions
Hypotonic Solutions
Mice
Myocytes, Cardiac
Osmosis
Time Factors
Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
topic_facet Bumetanide
Cell volume regulation
DIDS
HL-1 atrial myocytes
RVD
RVI
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
hypertonic solution
hypotonic solution
sodium potassium chloride cotransporter
bicarbonate chloride antiporter
isotonic solution
Ringer solution
sodium potassium chloride cotransporter
4,4' diisothiocyanatostilbene 2,2' disulfonic acid
bumetanide
diuretic agent
hypertonic solution
hypotonic solution
animal cell
animal experiment
article
biological activity
cell function
cell membrane transport
cell swelling
cell volume
cellular parameters
concentration response
enzyme inhibition
heart muscle cell
hyperosmotic stress
hypoosmotic stress
light intensity
light scattering
nonhuman
osmosis
osmotic stress
priority journal
regulatory mechanism
regulatory volume decrease
regulatory volume increase
Article
cell membrane
controlled study
illumination
mouse
water flow
animal
cardiac muscle cell
cell line
cell size
cytology
drug effects
time factor
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
Animals
Bumetanide
Cell Line
Cell Size
Diuretics
Hypertonic Solutions
Hypotonic Solutions
Mice
Myocytes, Cardiac
Osmosis
Time Factors
description Background/Aims: we have investigated whether cultured cardiomyocytes of the cell line HL-1 have the ability to perform regulatory volume responses both in hypotonic and hypertonic conditions. Furthermore, we characterized those regulatory responses and studied the effects of bumetanide and DIDS in volume regulation of HL-1 cells. Methods: we used a light scattering system to measure the transient volume changes of HL-1 cells when subjected to osmotic challenge. Results: We found that HL-1 cells correct for their volume excess by undergoing regulatory volume decrease (RVD), and also respond to hypertonic stress with a regulatory volume increase (RVI). Rate of RVD was 0.08 ± 0.04 intensity/min, and rate of RVI was 0.09 ± 0.01 intensity/min. Volume recovery was 83.68 ± 5.73 % for RVD and 92.3 ± 2.3 % for RVI. Bumetanide 50 μM inhibited volume recovery, from 92.3 ± 2.3 % (control) to 24.6 ± 8.8 % and reduced the rate of RVI from 0.070 ± 0.020 intensity/min (control) to 0.010 ± 0.005 intensity/min. 50 μM DIDS reduced volume recovery to 42.93 ± 7.7 % and rate of RVI, to 0.03 ± 0.01 intensity/min. Conclusions: these results suggest that bumetanide- and DIDS-sensitive mechanisms are involved in the RVI of HL-1 cells, which points to the involvement of the Na+/K+/2Cl- cotransporter and Cl-/bicarbonate exchanger in RVI, respectively. © 2014 S. Karger AG, Basel.
title Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
title_short Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
title_full Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
title_fullStr Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
title_full_unstemmed Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes
title_sort regulatory volume increase and regulatory volume decrease responses in hl-1 atrial myocytes
publishDate 2014
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10158987_v33_n6_p1745_Cacace
http://hdl.handle.net/20.500.12110/paper_10158987_v33_n6_p1745_Cacace
_version_ 1768544513078329344